Miranda Fernández-Serrano

6PUBLICATIONS
92CO-AUTHORS
Molecular targetsCheminformatics and quantitative structure-activity relationshipsCancer diagnosisHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 10, 2026
SMARCB1 Deficiency in Tumors Confers a Vulnerability to H3K27 Demethylase Inhibitors via Autophagy Disruption.

|Sep 14, 2024
Applying Molecular Modeling to the Design of Innovative, Non-Symmetrical CXCR4 Inhibitors with Potent Anticancer Activity.

Miquel Martínez-Asensio, Lluís Sàrrias, Gema Gorjón-de-Pablo

|Apr 03, 2023
C/EBPα Confers Dependence to Fatty Acid Anabolic Pathways and Vulnerability to Lipid Oxidative Stress-Induced Ferroptosis in FLT3-Mutant Leukemia.

Marie Sabatier, Rudy Birsen, Laura Lauture

|Jan 11, 2022
Histone Modifications and Their Targeting in Lymphoid Malignancies.

Miranda Fernández-Serrano, René Winkler, Juliana C Santos

|Sep 23, 2021
Antitumor Activity of the Novel BTK Inhibitor TG-1701 Is Associated with Disruption of Ikaros Signaling in Patients with B-cell Non-Hodgkin Lymphoma.

Marcelo Lima Ribeiro, Diana Reyes-Garau, Meritxell Vinyoles

|Jan 12, 2021
Immune-Checkpoint Inhibitors in B-Cell Lymphoma.

Marc Armengol, Juliana Carvalho Santos, Miranda Fernández-Serrano

Pageof 1

Frequent Collaborators

6 joint publications

Gaël Roué

3 joint publications

Juliana Carvalho Santos

1 joint publications

Marcelo Lima Ribeiro

1 joint publications

Núria Profitós Pelejà